Martin Pal
Cited by
Cited by
From cytokine to myokine: the emerging role of interleukin‐6 in metabolic regulation
M Pal, MA Febbraio, M Whitham
Immunology and cell biology 92 (4), 331-339, 2014
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ...
The Lancet Oncology 22 (11), 1507-1517, 2021
Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism
BF Belgardt, J Mauer, FT Wunderlich, MB Ernst, M Pal, G Spohn, ...
Proceedings of the National Academy of Sciences 107 (13), 6028-6033, 2010
The roles of c‐Jun NH2‐terminal kinases (JNKs) in obesity and insulin resistance
M Pal, MA Febbraio, GI Lancaster
The Journal of physiology 594 (2), 267-279, 2016
Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1
M Whitham, MHS Chan, M Pal, VB Matthews, O Prelovsek, S Lunke, ...
Journal of Biological Chemistry 287 (14), 10771-10779, 2012
Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance
E Tsaousidou, L Paeger, BF Belgardt, M Pal, CM Wunderlich, H Brönneke, ...
Cell reports 9 (4), 1495-1506, 2014
Loss of Roquin induces early death and immune deregulation but not autoimmunity
A Bertossi, M Aichinger, P Sansonetti, M Lech, F Neff, M Pal, ...
Journal of Experimental Medicine 208 (9), 1749-1756, 2011
Mosaic deficiency in mitochondrial oxidative metabolism promotes cardiac arrhythmia during aging
OR Baris, S Ederer, JFG Neuhaus, JC von Kleist-Retzow, CM Wunderlich, ...
Cell metabolism 21 (5), 667-677, 2015
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1
V Kohlhaas, SJ Blakemore, M Al-Maarri, N Nickel, M Pal, A Roth, ...
Blood, The Journal of the American Society of Hematology 137 (5), 646-660, 2021
Treatment of type 2 diabetes with the designer cytokine IC7Fc
M Findeisen, TL Allen, DC Henstridge, H Kammoun, AE Brandon, ...
Nature 574 (7776), 63-68, 2019
TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1
L Lionnard, P Duc, MS Brennan, AJ Kueh, M Pal, F Guardia, B Mojsa, ...
Cell Death & Differentiation 26 (5), 902-917, 2019
Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis and obesity-associated insulin resistance in mice
M Pal, CM Wunderlich, G Spohn, HS Brönneke, M Schmidt-Supprian, ...
PLoS One 8 (1), e54247, 2013
An update on using CRISPR/Cas9 in the one-cell stage mouse embryo for generating complex mutant alleles
AJ Kueh, M Pal, L Tai, Y Liao, GK Smyth, W Shi, MJ Herold
Cell Death & Differentiation 24 (10), 1821-1822, 2017
Adipocyte-specific deletion of IL-6 does not attenuate obesity-induced weight gain or glucose intolerance in mice
M Whitham, M Pal, T Petzold, M Hjorth, CL Egan, JS Brunner, E Estevez, ...
American Journal of Physiology-Endocrinology and Metabolism 317 (4), E597-E604, 2019
CRISPR base editing applications for identifying cancer-driving mutations
M Pal, MJ Herold
Biochemical Society Transactions 49 (1), 269-280, 2021
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance
Y Deng, ST Diepstraten, MA Potts, G Giner, S Trezise, AP Ng, G Healey, ...
Nature Communications 13 (1), 4739, 2022
LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin target in Tasmanian devil facial tumor disease
MP Ikonomopoulou, Y Lopez-Mancheno, MG Novelle, M Martinez-Una, ...
Cell Reports 34 (11), 2021
Case Study: CRISPR 101–a novel online learning course harnessing innovative ways to teach a complex biomolecular technology
M Pal, N Cranna, MJ Herold, K Bumsted O’Brien
Essays in Biochemistry 66 (1), 11-18, 2022
Genome-wide in vivo CRISPR screens identify GATOR1 as a TP53 induced tumour suppressor
S Mizutani, MA Potts, Y Deng, G Giner, S Diepstraten, AJ Kueh, M Pal, ...
bioRxiv, 2022.02. 16.480657, 2022
A novel CRISPR activation mouse enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
M Herold, Y Deng, S Diepstraten, M Potts, A Heidersbach, A Kueh, M Pal, ...
The system can't perform the operation now. Try again later.
Articles 1–20